Spire Healthcare Group (LON:SPI) Trading Down 16.7% – Here’s Why

Spire Healthcare Group plc (LON:SPI) shares fell 16.7% during mid-day trading on Wednesday . The company traded as low as GBX 185 and last traded at GBX 186.20. 28,162,176 shares were traded during mid-day trading, an increase of 1,724% from the average session volume of 1,544,102 shares. The stock had previously closed at GBX 223.50.

Wall Street Analysts Forecast Growth

Separately, JPMorgan Chase & Co. cut their price objective on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an “overweight” rating on the stock in a research report on Tuesday, August 5th. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of GBX 294.33.

Spire Healthcare Group Stock Performance

The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25. The firm has a market cap of £749.21 million, a PE ratio of 40.48, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The business has a 50 day simple moving average of GBX 234.27 and a two-hundred day simple moving average of GBX 222.02.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.